Evolus Inc (NAS:EOLS)
$ 13 0.07 (0.54%) Market Cap: 813.94 Mil Enterprise Value: 839.87 Mil PE Ratio: 0 PB Ratio: 43.33 GF Score: 55/100

Evolus Inc at Barclays Global Healthcare Conference Transcript

Mar 11, 2020 / 07:20PM GMT
Release Date Price: $5.91 (-2.15%)
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

Good afternoon, everyone. Thank you for dialing in. My name is Balaji Prasad. I cover specialty pharma for Barclays. Continuing our Virtual Health Care Conference sessions for the day, we have with us for the next session management team from Evolus. We have Lauren Silvernail, CFO and the EVP Corporate Development; and Ashwin Agarwal from Investor Relations. Lauren and Ashwin, thank you for joining us. Would you like to -- Lauren, would you like to provide a quick overview and kick start the proceedings, and then we could launch into our Q&A session?

Lauren P. Silvernail
Evolus, Inc. - CFO & Executive VP of Corporate Development

That sounds perfect. Balaji, I want to thank you so much for the invitation, the Barclays team and the Barclays access team for scrambling so that we could all still be on call today, even with the ongoing coronavirus crisis.

See, prior to taking any questions, I thought I'd start off with a quick update and why we believe we're a compelling investment

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot